Antimicrobial Agents and Chemotherapy, 1995-03, Vol.39 (3), p.602-607
1995
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Safety, tolerance, and pharmacokinetics of atevirdine mesylate (U-87201E) in asymptomatic human immunodeficiency virus-infected patients
- Ist Teil von
- Antimicrobial Agents and Chemotherapy, 1995-03, Vol.39 (3), p.602-607
- Ort / Verlag
- Washington, DC: American Society for Microbiology
- Erscheinungsjahr
- 1995
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology. For an alternate route to AAC .asm.org, visit: AAC
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0066-4804eISSN: 1098-6596DOI: 10.1128/AAC.39.3.602Titel-ID: cdi_highwire_asm_aac_39_3_602
- Format
- –
- Schlagworte
- Adult, Antibiotics. Antiinfectious agents. Antiparasitic agents, Antiviral Agents, Antiviral Agents - adverse effects, Antiviral Agents - pharmacokinetics, Biological and medical sciences, Clinical Trial, Double-Blind Method, HIV Seropositivity, HIV Seropositivity - metabolism, HIV-1, human immunodeficiency virus, Humans, Male, Medical sciences, Middle Aged, Pharmacology. Drug treatments, Piperazines, Piperazines - adverse effects, Piperazines - pharmacokinetics, Randomized Controlled Trial